Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:loteprednol_etabonate
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
S01BA14
|
| gptkbp:drugClass |
gptkb:Corticosteroid
|
| gptkbp:form |
ophthalmic suspension
|
| https://www.w3.org/2000/01/rdf-schema#label |
Alrex
|
| gptkbp:manufacturer |
gptkb:Bausch_&_Lomb
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
topical (eye)
|
| gptkbp:sideEffect |
headache
increased intraocular pressure eye irritation |
| gptkbp:usedFor |
treatment of allergic conjunctivitis
|
| gptkbp:bfsParent |
gptkb:Valeant_Pharmaceuticals
|
| gptkbp:bfsLayer |
6
|